Medical assistance in dying, also called assisted dying, is a legal, regulated medical practice in which healthcare professionals prescribe medications to patients for intentional death. This procedure is usually done in cases of severe or non-curative illness.
This practice has gained importance throughout the globe because more countries are considering adopting these laws. However, it is important to consider the negative impact of these procedures on healthcare professionals who are related and have direct access to harmful medications.
Assisted dying is highly significant to relieve patient suffering, but clinicians are more involved in making complex health decisions, administering life-ending drugs, and lethal drugs. When we compare the suicide rates compared to those of the general population, these healthcare professionals have shown higher rates due to multiple factors and burdens like occupational, emotional, and personal stressors. Their work and exposure to such drugs increase concerns about mental health and risk of self-harm. Healthcare workers involved in end-of-life care usually face ethical dilemmas, emotional exhaustion, and moral distress. Although assisted dying is tightly regulated for the safety of patients and autonomy, its psychological effect on clinicians is often overlooked.
Although limited data exist, constant exposure to death and access to powerful medications may strengthen self-harm risk, emphasizing the need for safeguards. This discussion investigates this intersection by analyzing mental, pharmacological, legal, and ethical health perspectives. It spotlights particularly the clinicians who are involved in assisted dying. It also explores the overlap between drugs used in assisted dying and those involved in healthcare professional suicides.
Assisted dying laws vary globally. Countries Belgium and the Netherlands have a well-regulated system, whereas in the case of Switzerland, the law permits suicide only under specific conditions. In North America, most U.S. states allow physician-assisted death. In Asia, assisted dying is largely prohibited, but there is an increasing debate. In Latin America, Colombia has legalized the practice, while many African nations are more concerned with basic care and palliative services.
In India, the ethical and legal landscape is evolving. The Supreme Court of India has recognized passive euthanasia under specific conditions. However, there are certain challenges related to these, like public awareness, clinician training, and implementation of these practices. The narcotics law in India also regulates access to medications used in end-of-life care and ensures access while preventing misuse.
Healthcare professionals face mental health risks from stress and ethical challenges, with enormous strain in assisted dying; prevention needs direct training, support, and multi-level strategies. Life-ending drugs also make the situation more complicated, as the same drugs can be abused; frequent exposure can increase the risk, and their control and monitoring are the key factors.
Both controls and mental health services, such as controlled access to drugs, monitoring, counseling, peer support, and training, are needed in prevention. With the spread of assisted dying, policies should safeguard patient rights and clinician well-being by promoting voluntary involvement, robust safeguards, and an equal, ethical stance.
Reference: Singh MP, TP. Assisted dying, pharmacological lethality, and suicide risk among healthcare workers: ethical, regulatory, and mental health dimensions. Cureus. 2026;18(2):e103876. doi:10.7759/cureus.103876
